{"altmetric_id":23465758,"counts":{"readers":{"mendeley":0,"citeulike":0,"connotea":0},"total":{"posts_count":9},"twitter":{"unique_users_count":8,"unique_users":["EUplatinum","JackRaph","urbano_anido","anloust","cristobalmd02","UroCourlancy","checarinitos","arrabalm8"],"posts_count":8},"facebook":{"unique_users_count":1,"unique_users":["164449413603387"],"posts_count":1}},"selected_quotes":["Influence of Prior Tyrosine Kinase Inhibitor on Survival for Patients with Metastatic Renal Cell Carcinoma"],"citation":{"altmetric_jid":"4f6fa4eb3cf058f610002875","authors":["Roviello, Giandomenico","Generali, Daniele"],"doi":"10.1016\/j.eururo.2017.07.019","first_seen_on":"2017-08-05T19:11:17+00:00","funders":["niehs"],"issns":["0302-2838","03022838"],"journal":"European Urology","last_mentioned_on":1502118519,"links":["http:\/\/www.europeanurology.com\/article\/S0302-2838(17)30643-7\/fulltext?rss=yes&utm_content=bufferd3d39&utm_medium=social&utm_source=twitter.com&utm_campaign=buffer"],"pmid":"28760645","pubdate":"2017-07-01T00:00:00+00:00","publisher":"Elsevier BV","publisher_subjects":[{"name":"Clinical Sciences","scheme":"era"}],"scopus_subjects":["Medicine","Health Sciences"],"title":"Influence of Prior Tyrosine Kinase Inhibitor on Survival for Patients with Metastatic Renal Cell Carcinoma Treated with Nivolumab or Cabozantinib: Data from a Literature-based Meta-analysis","type":"article"},"altmetric_score":{"score":5.15,"score_history":{"1y":5.15,"6m":5.15,"3m":5.15,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":5.15},"context_for_score":{"all":{"total_number_of_other_articles":8336644,"mean":7.0294968595789,"rank":1589765,"this_scored_higher_than_pct":80,"this_scored_higher_than":6744795,"rank_type":"exact","sample_size":8336644,"percentile":80},"similar_age_3m":{"total_number_of_other_articles":180748,"mean":12.198538266195,"rank":43320,"this_scored_higher_than_pct":75,"this_scored_higher_than":137299,"rank_type":"exact","sample_size":180748,"percentile":75},"this_journal":{"total_number_of_other_articles":2865,"mean":10.698339385475,"rank":1192,"this_scored_higher_than_pct":58,"this_scored_higher_than":1672,"rank_type":"exact","sample_size":2865,"percentile":58},"similar_age_this_journal_3m":{"total_number_of_other_articles":59,"mean":27.200862068966,"rank":50,"this_scored_higher_than_pct":15,"this_scored_higher_than":9,"rank_type":"exact","sample_size":59,"percentile":15}}},"demographics":{"poster_types":{"member_of_the_public":6,"practitioner":1,"science_communicator":1},"users":{"twitter":{"cohorts":{"Science communicators (journalists, bloggers, editors)":1,"Members of the public":6,"Practitioners (doctors, other healthcare professionals)":1}}},"geo":{"twitter":{"CA":1,"ES":2,"FR":1}}},"posts":{"twitter":[{"url":"http:\/\/twitter.com\/EUplatinum\/statuses\/893912261097644032","license":"gnip","citation_ids":[23465758],"posted_on":"2017-08-05T19:11:05+00:00","author":{"name":"European Urology","url":"http:\/\/www.europeanurology.com","image":"https:\/\/pbs.twimg.com\/profile_images\/862615016943607808\/kyH26ujj_normal.jpg","description":"European Urology | The Platinum Journal | Official Journal of EAU @Uroweb | Ranked #1 in Urology & Nephrology | Editor @JimCatto | Impact Factor 16.265","id_on_source":"EUplatinum","tweeter_id":"284508936","geo":{"lt":null,"ln":null},"followers":13795},"tweet_id":"893912261097644032"},{"url":"http:\/\/twitter.com\/JackRaph\/statuses\/893913803129335809","license":"gnip","rt":["EUplatinum"],"citation_ids":[23465758],"posted_on":"2017-08-05T19:17:13+00:00","author":{"name":"Jacques Raphael","image":"https:\/\/pbs.twimg.com\/profile_images\/862067863787524097\/mlT3JWcP_normal.jpg","description":"Clinical\/Research fellow at Sunnybrook Odette Cancer Centre","id_on_source":"JackRaph","tweeter_id":"84117245","geo":{"lt":60.10867,"ln":-113.64258,"country":"CA"},"followers":55},"tweet_id":"893913803129335809"},{"url":"http:\/\/twitter.com\/urbano_anido\/statuses\/893914819207639040","license":"gnip","rt":["EUplatinum"],"citation_ids":[23465758],"posted_on":"2017-08-05T19:21:15+00:00","author":{"name":"Urbano Anido","image":"https:\/\/pbs.twimg.com\/profile_images\/701328985590988800\/dFM9Y8VG_normal.jpg","description":"Father & husband | Scuba-diver | Medical oncologist | Own opinions & thoughts","id_on_source":"urbano_anido","tweeter_id":"2303944103","geo":{"lt":42.88052,"ln":-8.54569,"country":"ES"},"followers":447},"tweet_id":"893914819207639040"},{"url":"http:\/\/twitter.com\/anloust\/statuses\/893966071849508864","license":"gnip","rt":["EUplatinum"],"citation_ids":[23465758],"posted_on":"2017-08-05T22:44:55+00:00","author":{"name":"Anna Strand","image":"https:\/\/abs.twimg.com\/sticky\/default_profile_images\/default_profile_normal.png","id_on_source":"anloust","tweeter_id":"874755604962848768","geo":{"lt":null,"ln":null},"followers":1},"tweet_id":"893966071849508864"},{"url":"http:\/\/twitter.com\/cristobalmd02\/statuses\/894011818045095936","license":"gnip","rt":["EUplatinum"],"citation_ids":[23465758],"posted_on":"2017-08-06T01:46:42+00:00","author":{"name":"Dr Cristobal Diaz","image":"https:\/\/pbs.twimg.com\/profile_images\/888341619862192128\/veflISCk_normal.jpg","description":"Uro-Onc\u00f3logo","id_on_source":"cristobalmd02","tweeter_id":"2518526203","geo":{"lt":null,"ln":null},"followers":93},"tweet_id":"894011818045095936"},{"url":"http:\/\/twitter.com\/UroCourlancy\/statuses\/894129840491724800","license":"gnip","rt":["EUplatinum"],"citation_ids":[23465758],"posted_on":"2017-08-06T09:35:40+00:00","author":{"name":"UROLOGIE COURLANCY","url":"http:\/\/www.urologie-courlancy.com","image":"https:\/\/pbs.twimg.com\/profile_images\/586250330100338689\/we6JLwr9_normal.jpg","description":"SELARL d'Urologie de Courlancy - #urologie #cancer #incontinence #andrologie #lithiase #robotique #rein #vessie #prostate","id_on_source":"UroCourlancy","tweeter_id":"3152526015","geo":{"lt":49.25,"ln":4.03333,"country":"FR"},"followers":29},"tweet_id":"894129840491724800"},{"url":"http:\/\/twitter.com\/checarinitos\/statuses\/894572805991403520","license":"gnip","rt":["EUplatinum"],"citation_ids":[23465758],"posted_on":"2017-08-07T14:55:51+00:00","author":{"name":"Carlos Eugenio","image":"https:\/\/pbs.twimg.com\/profile_images\/683258176158986240\/CJTohYGv_normal.jpg","id_on_source":"checarinitos","tweeter_id":"2583421635","geo":{"lt":null,"ln":null},"followers":137},"tweet_id":"894572805991403520"},{"url":"http:\/\/twitter.com\/arrabalm8\/statuses\/894576027246178305","license":"gnip","rt":["EUplatinum"],"citation_ids":[23465758],"posted_on":"2017-08-07T15:08:39+00:00","author":{"name":"Miguel Arrabal","url":"http:\/\/urologiaarrabalm.blogspot.com","image":"https:\/\/pbs.twimg.com\/profile_images\/479892253314265088\/oSh_VSnJ_normal.jpeg","description":"Ur\u00f3logo\/Investigador en Servicio Andaluz de Salud y Departamento de Cirug\u00eda de la Universidad de Granada. Asociaci\u00f3n Andaluza y Espa\u00f1ola de Urolog\u00eda","id_on_source":"arrabalm8","tweeter_id":"1387057838","geo":{"lt":37.6,"ln":-4.5,"country":"ES"},"followers":115},"tweet_id":"894576027246178305"}],"facebook":[{"title":"Influence of Prior Tyrosine Kinase Inhibitor on Survival for Patients with Metastatic Renal Cell Carcinoma Treated with Nivolumab or Cabozantinib: Data from a Literature-based Meta-analysis","url":"https:\/\/www.facebook.com\/permalink.php?story_fbid=1401861119862204&id=164449413603387","license":"public","citation_ids":[23465758],"posted_on":"2017-08-05T19:11:06+00:00","summary":"Influence of Prior Tyrosine Kinase Inhibitor on Survival for Patients with Metastatic Renal Cell Carcinoma https:\/\/t.co\/E1qqigEHwf","author":{"name":"European Urology","url":"https:\/\/www.facebook.com\/164449413603387","facebook_wall_name":"European Urology","image":"https:\/\/graph.facebook.com\/164449413603387\/picture","id_on_source":"164449413603387"}}]}}